[go: up one dir, main page]

Hahn et al., 2020 - Google Patents

Longitudinal associations of the cystic fibrosis airway microbiome and volatile metabolites: a case study

Hahn et al., 2020

View HTML
Document ID
4303867303306838976
Author
Hahn A
Whiteson K
Davis T
Phan J
Sami I
Koumbourlis A
Freishtat R
Crandall K
Bean H
Publication year
Publication venue
Frontiers in Cellular and Infection Microbiology

External Links

Snippet

The identification of 16S rDNA biomarkers from respiratory samples to describe the continuum of clinical disease states within persons having cystic fibrosis (CF) has remained elusive. We sought to combine 16S, metagenomics, and metabolomics data to describe …
Continue reading at www.frontiersin.org (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
    • C12Q1/04—Determining presence or kind of micro-organism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology

Similar Documents

Publication Publication Date Title
Hahn et al. Longitudinal associations of the cystic fibrosis airway microbiome and volatile metabolites: a case study
Woo et al. A longitudinal characterization of the non-cystic fibrosis bronchiectasis airway microbiome
Nelson et al. Human and extracellular DNA depletion for metagenomic analysis of complex clinical infection samples yields optimized viable microbiome profiles
Wade et al. Profiling of oral bacterial communities
Nearing et al. Infectious complications are associated with alterations in the gut microbiome in pediatric patients with acute lymphoblastic leukemia
Wipperman et al. Antibiotic treatment for Tuberculosis induces a profound dysbiosis of the microbiome that persists long after therapy is completed
Horiba et al. Comprehensive detection of pathogens in immunocompromised children with bloodstream infections by next-generation sequencing
Dabdoub et al. Comparative metagenomics reveals taxonomically idiosyncratic yet functionally congruent communities in periodontitis
Chuang et al. Influence of genospecies of Acinetobacter baumannii complex on clinical outcomes of patients with Acinetobacter bacteremia
Ditz et al. Sputum microbiome profiling in COPD: beyond singular pathogen detection
Rozas et al. MinION™ nanopore sequencing of skin microbiome 16S and 16S-23S rRNA gene amplicons
Gan et al. Combined nanopore adaptive sequencing and enzyme-based host depletion efficiently enriched microbial sequences and identified missing respiratory pathogens
Lin et al. Community-onset Klebsiella pneumoniae pneumonia in Taiwan: clinical features of the disease and associated microbiological characteristics of isolates from pneumonia and nasopharynx
Baxter et al. Intravenous antibiotics reduce the presence of Aspergillus in adult cystic fibrosis sputum
Yang et al. Association of exacerbation phenotype with the sputum microbiome in chronic obstructive pulmonary disease patients during the clinically stable state
Nasir et al. Volatile molecules from bronchoalveolar lavage fluid can ‘rule-in’Pseudomonas aeruginosa and ‘rule-out’Staphylococcus aureus infections in cystic fibrosis patients
Brinkac et al. Spatial and environmental variation of the human hair microbiota
Wang et al. Biofilm formation is not associated with worse outcome in Acinetobacter baumannii bacteraemic pneumonia
Garcia-Nuñez et al. Bronchial microbiome, PA biofilm-forming capacity and exacerbation in severe COPD patients colonized by P. aeruginosa
Thänert et al. Molecular profiling of tissue biopsies reveals unique signatures associated with streptococcal necrotizing soft tissue infections
Wang et al. Characteristics of fecal microbiota and machine learning strategy for fecal invasive biomarkers in pediatric inflammatory bowel disease
de Wert et al. The cutaneous microbiome in hospitalized patients with pressure ulcers
Wang et al. The sputum microbiome associated with different sub-types of AECOPD in a Chinese cohort
Barrett et al. Cell free DNA from respiratory pathogens is detectable in the blood plasma of cystic fibrosis patients
Ahmed et al. Longitudinal development of the airway microbiota in infants with cystic fibrosis